Patent · US Active

Composition comprising Ulmi cortex extracts for inhibiting ovotoxicity

US10434128B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2018
Grant dateOct 8, 2019
Priority date
Expiry dateJun 28, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2236/331
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a method of treating ovotoxicity of an individual, including administering an Ulmi cortex extract to an individual in need of treatment. The present disclosure may exhibit an effect of preventing, alleviating, or treating ovarian aging or premature ovarian failure by inhibiting oxidative stress or ovotoxicity of the ovaries.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.